Takeda Pharmaceutical (TAK) Dividend Coverage Ratio Growth (3y) (2021 - 2026)
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Dividend Coverage Ratio Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.38 Bn | 624.62 Bn | 17.26 Bn | 1.02% |
| 2 | AbbVie | 443.13 Bn | 436.56 Bn | 12.70 Bn | 15.11% |
| 3 | Merck | 365.40 Bn | 358.26 Bn | 12.21 Bn | 41.83% |
| 4 | Novartis Ag | 266.79 Bn | 259.10 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -27.98% |
| 6 | Sanofi | 52.39 Bn | 45.00 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.92 Bn | 43.92 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.55 Bn | 18.88 Bn | 683.80 Mn | - |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.18 Bn | 5.10 Bn | 3.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.31% |
| Sep 30, 2025 | -64.30% |
| Jun 30, 2025 | -1.62% |
| Mar 31, 2025 | -140.72% |
| Dec 31, 2024 | 39.46% |
| Sep 30, 2024 | -68.26% |
| Jun 30, 2024 | 12.88% |
| Mar 31, 2024 | 22.84% |
| Dec 31, 2023 | -33.50% |
| Sep 30, 2023 | -307.15% |
| Jun 30, 2023 | -3.32% |
| Mar 31, 2023 | -265.08% |
| Sep 30, 2022 | -39.12% |
| Jun 30, 2022 | -148.97% |
| Mar 31, 2022 | 27.32% |
| Dec 31, 2021 | -38.08% |
| Sep 30, 2021 | 35.82% |
| Jun 30, 2021 | 4.69% |
| Mar 31, 2021 | -7.61% |